Anti - Neoplastic Agents Market Research Report - Global Forecast to 2027

Anti-Neoplastic Agents Market Information, by type (alkylating and alkylating-like agents, antimetabolites, antitumor antibiotics, plant alkaloids, hormonal agents, and miscellaneous agents), by end user (hospitals, clinics, research institutes, cancer rehabilitation centers and others) - Forecast to 2027

ID: MRFR/Pharma/1699-HCR | February 2021 | Region: Global | 80 pages

Market Synopsis of Anti-Neoplastic Agents Market:


Antineoplastic agents are the type of drugs that inhibit the maturation and proliferation of neoplasms. These agents travel into the human body and destroys the cancerous cells. These drugs/agents are not only used for different cancers but are used in conjunction with surgery, radiotherapy and immunotherapy for many solid tumors particularly for metastatic. The market for antineoplastic is growing at a reasonably good rate. Growing new cases for neoplasms around the globe and increasing need for cost effective treatments to cure the neoplasms has fueled the growth of anti-neoplastic agents market. 


The global market for anti-neoplastic agents is expected to reach around USD 150 billion by the end of the forecast period and is expected to grow at a striking CAGR of ~8.0% during the forecast period 2016-2022.


Key Players for Anti-Neoplastic Agents Market: Some of the key players in this market are: Amgen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Bayer AG, Aspen Holdings, Pfizer Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Teva pharmaceutical Industries Ltd, Genentech Inc., AbbVie Inc. and others.


Intended Audience:



  • Anti-neoplastic Agents Producers

  • Private Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Government Research Laboratories


Market Segments: 

Anti-neoplastic agents market has been segmented on the basis of type which comprises alkylating and alkylating-like agents, antimetabolites, antitumor antibiotics, plant alkaloids, hormonal agents, and miscellaneous agents. On the basis of end users; market is segmented into hospitals, clinics, research institutes, cancer rehabilitation centers and others.


Anti-Neoplastic Agents Market, by Type, 2015 & 2022 (USD Million):


Global Anti-Neoplastic Agents Market, by Type, 2015 & 2022 (USD Million) 


Study Objectives Anti-Neoplastic Agents Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Anti-neoplastic agents market  

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by end user and other sub segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.


Regional Analysis of Anti-Neoplastic Agents Market: 

Globally, Americas is the largest market for anti-neoplastic agents. The Americas market for anti-neoplastic agents is expected to reach around USD 111 billion by the end of the forecast period of 2016-2022.


Europe is the second-largest market for anti-neoplastic agents. Asia pacific region is expected to be fastest growing region in anti-neoplastic agents market.


Anti - Neoplastic Agents Market, by Region



  • Americas


    • North America


      • US

      • Canada


    • Latin America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa



The report for Anti-Neoplastic Agents Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 150 Billion
  CAGR   8% (2016-2022)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   type and end user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Amgen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Bayer AG, Aspen Holdings, Pfizer Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Teva pharmaceutical Industries Ltd, Genentech Inc., AbbVie Inc.
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments
  Key Market Drivers   Growing new cases for neoplasms around the globe and increasing need for cost effective treatments to cure the neoplasms


Speak to Analyst Ask for Customization

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Anti-Neoplastic Agents Market, by Type

5.1 Introduction

5.1.1 Alkylating and Alkylating-like Agents

5.1.2 Antimetabolites

5.1.3 Antitumor Antibiotics

5.1.4 Plant Alkaloids

5.1.5 Hormonal Agents

5.1.6 Miscellaneous Agents

6 Global Anti-Neoplastic Agents Market, by End User

6.1 Introduction

6.1.1 Hospitals

6.1.2 Clinics

6.1.3 Research Institutes

6.1.4 Cancer Rehabilitation Centers

6.1.5 Others

7 Global Anti-Neoplastic Agents Market, by Regions

7.1 Introduction

7.1.1 Americas

7.1.1.1 North America

7.1.1.2 South America

7.1.2 Europe

7.1.2.1 Germany

7.1.2.2 France

7.1.2.3 UK

7.1.2.4 Italy

7.1.2.5 Spain

7.1.2.6 Rest of Europe

7.1.3 Asia Pacific

7.1.3.1 Japan

7.1.3.2 China

7.1.3.3 India

7.1.3.4 Republic of Korea

7.1.3.5 Rest of Asia Pacific

7.1.4 Middle East & Africa

8 Company Landscape

8.1 Introduction

8.1.1 Mergers Acquisitions

8.1.2 Collaborations

8.1.3 Release/New Product Launches

8.1.4 Other (Expansion, Updates, Partnership)

9 Company Profile

9.1 AbbVie Inc.

9.1.1 Company Overview

9.1.2 Product/Business Segment Overview

9.1.3 Financials

9.1.4 Key Developments

9.1.5 SWOT Analysis

9.2 Amgen Inc.

9.2.1 Overview

9.2.2 Product/Business Segment Overview

9.2.3 Financials

9.2.4 Key Developments

9.2.5 SWOT Analysis

9.3 Aspen Holdings

9.3.1 Overview

9.3.2 Product/Business Segment Overview

9.3.3 Financials

9.3.4 Key Developments

9.3.5 SWOT Analysis

9.4 Baxter Healthcare Corporation

9.4.1 Overview

9.4.2 Product/Business Segment Overview

9.4.3 Financials

9.4.4 Key Developments

9.4.5 SWOT Analysis

9.5 Bayer AG

9.5.1 Overview

9.5.2 Product/Business Segment Overview

9.5.3 Financials

9.5.4 Key Developments

9.5.5 SWOT Analysis

9.6 Boehringer Ingelheim GmbH

9.6.1 Overview

9.6.2 Product/Business Segment Overview

9.6.3 Financials

9.6.4 Key Developments

9.6.5 SWOT Analysis

9.7 Bristol-Myers Squibb Company

9.7.1 Overview

9.7.2 Product/Business Segment Overview

9.7.3 Financials

9.7.4 Key Developments

9.7.5 SWOT Analysis

9.8 F. Hoffmann-La Roche Ltd

9.8.1 Overview

9.8.2 Product/Business Segment Overview

9.8.3 Financials

9.8.4 Key Developments

9.8.5 SWOT Analysis

9.9 Genentech Inc.

9.9.1 Overview

9.9.2 Product/Business Segment Overview

9.9.3 Financials

9.9.4 Key Developments

9.9.5 SWOT Analysis

9.10 Pfizer Inc.

9.10.1 Overview

9.10.2 Product/Business Segment Overview

9.10.3 Financials

9.10.4 Key Developments

9.10.5 SWOT Analysis

9.11 Teva pharmaceutical Industries Ltd

9.11.1 Overview

9.11.2 Product/Business Segment Overview

9.11.3 Financials

9.11.4 Key Developments

9.11. SWOT Analysis

9.12 Others

10 Appendix

List of Tables

TABLE 1 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, 2020-2027 (USD MILLION)

TABLE 2 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY TYPE

FIGURE 4 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY END USER

FIGURE 5 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY REGION

FIGURE 6 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)